{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "Mercury", "longName": "Mercury Biopharmaceutical Corporation", "messageBoardId": "finmb_1802626166", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChangePercent": -3.030303, "regularMarketPrice": 24.0, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.19191921, "fiftyTwoWeekLow": 6.65, "fiftyTwoWeekHigh": 29.7, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "sharesOutstanding": 405972000, "bookValue": 0.447, "fiftyDayAverage": 25.51696, "fiftyDayAverageChange": -1.5169601, "fiftyDayAverageChangePercent": -0.05944909, "twoHundredDayAverage": 20.32475, "twoHundredDayAverageChange": 3.675249, "twoHundredDayAverageChangePercent": 0.18082628, "marketCap": 9743328256, "priceToBook": 53.691277, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -0.75, "regularMarketTime": 1684133802, "regularMarketDayHigh": 25.0, "regularMarketDayRange": "23.85 - 25.0", "regularMarketDayLow": 23.85, "regularMarketVolume": 1207136, "regularMarketPreviousClose": 24.75, "bid": 24.2, "ask": 24.0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 25.0, "averageDailyVolume3Month": 2633436, "averageDailyVolume10Day": 966904, "fiftyTwoWeekLowChange": 17.35, "fiftyTwoWeekLowChangePercent": 2.6090226, "fiftyTwoWeekRange": "6.65 - 29.7", "fiftyTwoWeekHighChange": -5.700001, "firstTradeDateMilliseconds": 1671757200000, "symbol": "6932.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "15th Floor", "address2": "No. 653, Bannan Road Zhonghe District", "city": "New Taipei City", "country": "Taiwan", "phone": "886 2 8221 2020", "website": "https://merdury.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.", "fullTimeEmployees": 16, "companyOfficers": [], "maxAge": 86400}}], "error": null}}